New report recommends inclusive approach to 'horizon scanning'

May 24, 2022 Latest News BioPharma News of the Day

This is a preview of subscriber content

Subscribe now to continue reading.

A new report commissioned by Bristol Myers Squibb has suggested an approach to the formal horizon scanning that will be introduced under the federal government's new agreement with Medicines Australia. …

Subscribe now to continue reading.

Latest Video

The mirage of US pharmaceutical pricing and how it could obscure the impact of 'MFN'
October 22, 2025 - Latest News
'Patient-centric partnerships will unlock brighter and more equitable outcomes for all'
October 21, 2025 - Latest News
FOI reforms set back transparency decades and will impact public health decision-making
October 21, 2025 - Latest News
Services Australia reports record number of processed PBS prescriptions
October 21, 2025 - Latest News
Astellas' XTANDI achieves landmark survival milestone in prostate cancer
October 21, 2025 - Latest News

New report recommends inclusive approach to 'horizon scanning'

This is a preview of subscriber content

Latest Video

Most Read

The mirage of US pharmaceutical pricing and how it could obscure the impact of 'MFN'

'Patient-centric partnerships will unlock brighter and more equitable outcomes for all'

FOI reforms set back transparency decades and will impact public health decision-making

Services Australia reports record number of processed PBS prescriptions

Astellas' XTANDI achieves landmark survival milestone in prostate cancer

New Stories

A perspective that rightly belongs in a time capsule from the 1990s

Global focus intensifies as AusBiotech strengthens trade, partnerships and international engagement

Queensland resources sector backs prevention-first health push to boost workforce productivity

Omico appoints Richard Vines as new Chair as it strengthens national precision oncology agenda

New Zealand identified as a ‘major outlier’ in OECD medicines investment

Island Pharmaceuticals secures FDA response date for Galidesivir approval pathway

Noxopharm granted first US patent for Sofra immune-modulation platform

Sign In

New report recommends inclusive approach to 'horizon scanning'

This is a preview of subscriber content

Latest Video

Most Read

The mirage of US pharmaceutical pricing and how it could obscure the impact of 'MFN'

'Patient-centric partnerships will unlock brighter and more equitable outcomes for all'

FOI reforms set back transparency decades and will impact public health decision-making

Services Australia reports record number of processed PBS prescriptions

Astellas' XTANDI achieves landmark survival milestone in prostate cancer

Follow Us

New Stories

A perspective that rightly belongs in a time capsule from the 1990s

Global focus intensifies as AusBiotech strengthens trade, partnerships and international engagement

Queensland resources sector backs prevention-first health push to boost workforce productivity

Omico appoints Richard Vines as new Chair as it strengthens national precision oncology agenda

New Zealand identified as a ‘major outlier’ in OECD medicines investment

Island Pharmaceuticals secures FDA response date for Galidesivir approval pathway

Noxopharm granted first US patent for Sofra immune-modulation platform